Federal Supply Schedule V797D70231
Award Date
9/30/17
Last Date to Order
9/29/26
Federal Agency
Veterans Integrated Service Network 12
Awardee
Mylan Institutional Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Fixed Price with Economic Price Adjustment
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
This Federal Supply Schedule contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a division of the U.S. Department of Veterans Affairs (VA), to Mylan Pharmaceuticals Inc. The contract, classified under FSS-61-IB for Pharmaceuticals and Drugs, has a ceiling value of $364,546,690.00 and a period of performance through December 31, 2027. Under this multiple-award Schedule contract, Mylan will provide a comprehensive range of pharmaceutical and hematology-related products...
This Federal Supply Schedule (FSS) contract, awarded by the Department of Veterans Affairs (VA) to Exela Pharma Sciences LLC, is for the procurement of pharmaceuticals, drugs, and hematology-related products under FSS-61-IB. The contract has a ceiling value of $3,030,000.00 and a period of performance through September 28, 2024. As a multiple-award schedule contract, this FSS allows the VA and other eligible federal agencies to issue task orders for a wide range of pharmaceutical and drug...
This is a Federal Supply Schedule (FSS) contract awarded by the Department of Veterans Affairs (VA) to Metuchen Pharmaceuticals LLC. The contract is for Pharmaceuticals and Drugs (FSS-61-IB) and has a ceiling value of $6,800,000 with a period of performance through February 14, 2025. The contract aims to procure a variety of pharmaceutical and hematology-related products for the VA's Veterans Integrated Service Network 12. As an FSS contract, it allows for the VA and other federal agencies to...
This Federal Supply Schedule contract, awarded to Mylan Specialty LP by the Department of Veterans Affairs Veterans Health Administration, has a potential value of over $514 million and runs through January 2027. The contract provides for the procurement of pharmaceuticals, drugs, hematology products, and related medical supplies to serve the healthcare needs of veterans. As a multiple award Federal Supply Schedule contract under the Pharmaceuticals and Drugs schedule, this agreement enables...
The contract is a Federal Supply Schedule (FSS) award to Mayne Pharma Commercial LLC, a foreign-owned, for-profit manufacturer of goods. The contract is for pharmaceutical and hematology-related products under FSS Schedule 65 I B, with a contract ceiling value of $53,029,735.90 and a period of performance from July 15, 2025 to July 14, 2030. The contracting agency is the Veterans Integrated Service Network 12, a civilian federal agency. The contract does not have any set-asides and was awarded...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 awarded a Federal Supply Schedule (FSS) contract to Genericus, Inc. under the Pharmaceuticals and Drugs (FSS-61-IB) FSS master schedule. The contract, valued at up to $225,000.00, enables the procurement of drugs, pharmaceuticals, and hematology-related products. As an FSS contract, this is a multiple award vehicle that allows for indefinite delivery of the specified products and services...
The Federal Supply Schedule (FSS) contract award, with ID 36F79723D0229, was granted to Legacy Pharma USA, Inc., a foreign-owned, self-certified small disadvantaged business, for the provision of DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS. This multiple-award contract has a ceiling value of $6,150,000.00 and a period of performance ending on September 14, 2028. The contracting agency is the Veterans Integrated Service Network 12 (VISN 12), a civilian agency within the Department...
This Federal Supply Schedule (FSS) contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian federal agency, to Mycovia Pharmaceuticals, Inc. The contract is for Drugs, Pharmaceuticals, & Hematology Related Products under FSS Schedule 65 I B. The contract has a ceiling value of $25,000.00 and a period of performance through March 14, 2023. This is a multiple award, non-set-aside contract. The contract aims to procure pharmaceutical and hematology-related...
The Federal Supply Schedule contract award referenced is for the procurement of drugs, pharmaceuticals, and hematology-related products (FSS Contract 65 I B) by the U.S. Department of Veterans Affairs (VA), Veterans Integrated Service Network 12. The prime contractor is Haleon US LP, a for-profit manufacturer of goods. The contract has a total ceiling value of $9,867,650.00 and a period of performance extending through September 30, 2026. This is a multiple award schedule contract, meaning it...
This Federal Supply Schedule contract, awarded by the Department of Veterans Affairs (VA), provides for the delivery of drugs, pharmaceuticals, and hematology-related products. The contract has a ceiling value of $174,737,620.00 and a period of performance through March 31, 2028. The prime contractor for this multiple award contract is Kowa Pharmaceuticals America Inc., a for-profit manufacturer of goods. The contract does not utilize any set-asides. The scope of the contract encompasses a...
Name | Description | Awardee | Potential Value (Click to sort descending) | Award Date (Click to sort descending) | Completion Date (Click to sort descending) | Updated At (Click to sort descending) |
|---|---|---|---|---|---|---|
Delivery Order V797D70231-75P00220F80029 | Mylan Institutional Inc. | $10.1k | 1/3/20 | 1/3/20 | 7/16/20 |